Jynneos NDC 50632-023

Product information

Brand name (proprietary)

Jynneos

Generic name (nonproprietary)

vaccinia virus modified strain ankara-bavarian nordic non-replicating antigen

Active ingredients

Vaccinia virus modified strain ankara-bavarian nordic non-replicating antigen — 50000000 1/.5mL

Dosage form

Injection, Suspension

Route

Subcutaneous

Labeler

Bavarian Nordic A/S

Product type

Vaccine

Marketing category

BLA — Biologics License ApplicationApplication BLA 125678

Marketing start

Feb 14, 2025

Listing expires

Dec 31, 2026

Identifiers

Product ID 50632-023_b8f81332-4a93-4b01-89b9-3952565ab2e9SPL ID b8f81332-4a93-4b01-89b9-3952565ab2e9

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Immunization administration (CPT 90460–90474)

Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.

How CPT relates to drug billing

NDC on a medical claim

N450632002302 followed by a unit qualifier and the quantity Copy

Package 50632-0023-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under BLA 125678

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.